Deal snapshot: Castle Biosciences Closes Acquisition of Diagnostics Company AltheaDx.

MANews-(C)2009-2022

US-based medical diagnostics developer Castle Biosciences, Inc. (NASDAQ: CSTL) has closed the acquisition of molecular diagnostics company AltheaDx, Inc, Castle said.

AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics testing services that are...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT